Goldman Sachs raised the firm’s price target on Teradyne (TER) to $85 from $80 but keeps a Sell rating on the shares after its Q2 results and guidance. The firm expects the stock to trade higher given the management’s optimistic commentary surrounding Teradyne’s AI-centric opportunities in custom compute and memory despite reporting a tepid quarter with guidance that came in below the Street, the analyst tells investors in a research note. Investor expectations were low heading into the quarter, particularly in light of the stock’s significant underperformance year-to-date, but the company has made solid progress on several fronts, with solid design win momentum in custom compute silicon and memory test, the firm added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TER:
- Cautious Hold Rating for Teradyne Amid Competitive Pressures and NVIDIA Expansion Potential
- Teradyne upgraded to Equal Weight from Underweight at Morgan Stanley
- Teradyne’s Strong Semiconductor Testing Performance and Strategic Partnerships Justify Buy Rating
- Teradyne price target raised to $130 from $100 at TD Cowen
- Early notable gainers among liquid option names on July 30th